External validity of randomised controlled trials idiopathic pulmonary fibrosis [5]

European Respiratory Journal

Volumn 27, Issue 5, 2006, Pages 1072-

  Thomeer, M ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL ASSESSMENT; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; EXTERNAL VALIDITY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; GENERAL PRACTICE; HUMAN; IDIOPATHIC DISEASE; INCIDENCE; LETTER; LUNG FIBROSIS; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RARE DISEASE; SENSITIVITY AND SPECIFICITY; TERTIARY HEALTH CARE; CANADA; COMMUNITY CARE; EUROPE; EVIDENCE BASED PRACTICE; GENERAL PRACTITIONER; MEDICAL DECISION MAKING; MEDICAL EXPERT; MEDICAL SPECIALIST; PATIENT ASSESSMENT; PATIENT REFERRAL; PRACTICE GUIDELINE; PROFESSIONAL COMPETENCE; UNITED STATES; CONTROLLED CLINICAL TRIAL; NOTE; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STATISTICS;

HUMANS; PULMONARY FIBROSIS; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS;

EID: 33845479439     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.06.00151305     Document Type: Letter

References (3)

1. Johnson WC, Raghu G. Clinical trials in idiopathic pulmonary fibrosis: a word of caution concerning choice of outcome measures. Eur Respir J 2005; 26: 755-758.
2. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?". Lancet 2005; 365: 82-93.
3. Knottnerus JA, van Weel C, Muris, JW. Evaluation of diagnostic procedures. BMJ 2002; 324: 477-480.